Errika Kossiva: Plasma is a True “Gift of Life”
Errika Kossiva, Patient Advocacy and Communication Lead Greece, Cyprus and Malta at Takeda, shared on LinkedIn:
”Last week, our General Manager Dimitris Papageorgiou, highlighted the vital role of Plasma and Plasma-Derived Therapies for patients and society by participating in the 1st Conference of “ARMONIA” Patient Association, titled “Living with Primary Immunodeficiency: Access, Treatment, Support.”
Plasma is a true “gift of life”, enabling life-saving treatments for people with rare and complex diseases, often with no alternative therapeutic options.
Yet Europe – including Greece – remains heavily dependent on plasma collected in the US to meet its needs.
Greece also shows lower per capita consumption of PDTs compared with many EU countries, underlining the need for a modern National Plasma Framework that will: accurately capture patients’ real needs, ensure adequate supply and uninterrupted access and encourage plasma donations.
At Takeda Hellas we are committed to collaborating with all stakeholders to secure sustainable, timely access to plasma-derived therapies for every patient who needs them.”
Stay updated with Hemostasis Today.
-
Aug 24, 2026, 18:13Chokri Ben Lamine: Ruxolitinib – Comprehensive Clinical Reference
-
Aug 24, 2026, 18:10Yazan Abou-Ismail: ClotCast Episode 8 – What Are Platelets?
-
Aug 24, 2026, 17:11Kristin Neves: Which Hematologic Parameters Guide Your PV Treatment Decisions?
-
Aug 24, 2026, 17:00Should Hormone Therapy Automatically Stop After a Thrombosis? – Thrombosis Canada
-
Aug 24, 2026, 16:52Davide Capodanno: 10 Trials to Watch at the ESC Hot Lines
-
Aug 24, 2026, 16:48Mohd Ashhad: The Science Behind a Safe Transfusion
-
Aug 24, 2026, 16:38PCSK9i Is a Powerful Lipid-Lowering Strategy – But Is It Also Anti-Inflammatory?- JACC Journals
-
Aug 24, 2026, 16:36Alejandro González Veliz։ Does ACC/AHA Lesion Complexity Still Matter?
-
Aug 24, 2026, 16:21Kamlesh Darji: Paraneoplastic Syndromes – Tumor with or without Mediator